In regards to rs769446, Ereqat et al. investigated the impact of APOE gene variations on the risk of dyslipidemia in diabetes, and no statistical differences were observed in rs449647 variants among T2D patients with and without dyslipidemia [25]. This evidence concerns the gene APOE and metabolic syndrome.